Page last updated: 2024-08-26

becatecarin and Cholera Infantum

becatecarin has been researched along with Cholera Infantum in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alberti, D; Arzoomanian, R; Binger, K; Cleary, J; Dresen, A; Feierabend, C; Marnoccha, R; Merchant, J; Thomas, J; Tutsch, K; Wilding, G	1

Trials

1 trial(s) available for becatecarin and Cholera Infantum

Article	Year
Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats. Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Glucosides; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia	2002

Article

Year

Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2002, Volume: 8, Issue:7

Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Carbazoles; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Glucosides; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Neutropenia; Thrombocytopenia

2002